EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech
For years, AI in drug discovery has been a promise—billions invested, hundreds of papers published, dozens of startups founded, but actual drugs coming out the other end? Not yet. This is changing in 2026. Several AI-discovered drug candidates are now entering mid-to-late stage clinical trials. This is the year the…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Data Science With Sam
See all episodes →
EP 48: From Pilots to Productivity: What It Actually Takes to Make AI Work in the Enterprise
EP 47: The AI Pioneer Who Decided Privacy Matters More Than Hype
EP 46: Fix the Foundation First: Why Your Data Strategy Is Failing Before the AI Gets Involved
Similar episodes from other shows
More like Data Science With Sam →
EP 27: AI Revolutionizing Drug Discovery (2023 - 2025)
The 10 Biggest AI Stories of 2025
🔬 Training Transformers to solve 95% failure rate of Cancer Trials — Ron Alfa & Daniel Bear, Noetik
#202 Raphael Townshend: How AI and RNA Tech is Transforming Drug Discovery (Inside Atomic AI)
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.